Update: Respiratory Syncytial Virus Activity - United States, 1997-98 Season

Morbidity and Mortality Weekly Report

Volumn 46, Issue 49, 1997, Pages 1163-1165

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPIDEMIC; HEALTH SURVEY; HUMAN; SEASON; UNITED STATES; VIRUS INFECTION;

DISEASE OUTBREAKS; HUMANS; POPULATION SURVEILLANCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEASONS; UNITED STATES;

EID: 0031565918     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Institute of Medicine. Appendix N: prospects for immunizing against respiratory syncytial virus. In: New vaccine development: establishing priorities - Volume 1: diseases of importance in the United States. Washington, DC: National Academy Press, 1985:397-409.
2. Gilchrist S, Török TJ, Gary HE Jr, Alexander JP, Anderson LJ. National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis 1994;170:986-90.
3. Török TJ, Clarke MJ, Holman RC, Anderson LJ. Temporal and spatial trends in respiratory syncytial virus activity in the United States, 1990-1996 [Abstract]. Presented at: RSV after 40 years: an anniversary symposium. Charleston, South Carolina, November 9-12, 1996.
4. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996;174:456-62.
5. Mlinaric-Galinovic G, Falsey AR, Walsh EE. Respiratory syncytial virus infection in the elderly. Eur J Clin Microbiol Infect Dis 1996;15:777-81.
6. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995;21:376-9.
7. CDC. Guideline for prevention of nosocomial pneumonia. Resp Care 1994;39:1191-236.
8. Committee on Infectious Diseases, American Academy of Pediatrics. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 1996; 97:137-40.
9. Committee on Infectious Diseases, Committee on Fetus and Newborn, American Academy of Pediatrics. Respiratory syncytial virus immune globulin intravenous: indications for use. Pediatrics 1997;99:645-50.
10. Murphy BR, Hall SL, Kulkarni AB, et al. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Research 1994;32:13-36.